Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study
- 25 November 2005
- journal article
- research article
- Published by Elsevier
- Vol. 44 (2) , 291-301
- https://doi.org/10.1016/j.jhep.2005.10.021
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interferon Alfacon-1 and Ribavirin Versus Interferon ?-2b and Ribavirin in the Treatment of Chronic Hepatitis CDigestive Diseases and Sciences, 2005
- Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment[1], [2] and [3] 1 2 3☆Gastroenterology, 2004
- A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis CJournal of Hepatology, 2003
- Treatment of chronic hepatitis C with PEGylated interferon and ribavirinCurrent Gastroenterology Reports, 2002
- Induction interferon therapy in naïve patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefitAlimentary Pharmacology & Therapeutics, 2001
- A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotypeAmerican Journal of Gastroenterology, 2000
- Re-treatment of chronic hepatitis C with consensus interferonHepatology, 1998
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trialHepatology, 1997
- The Biologic Activity and Molecular Characterization of a Novel Synthetic Interferon-Alpha Species, Consensus InterferonJournal of Interferon & Cytokine Research, 1996
- A Comparison of Interferon-Con1 with Natural Recombinant Interferons-α: Antiviral, Antiproliferative, and Natural Killer-Inducing ActivitiesJournal of Interferon Research, 1992